Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 HemostemixNetscientificAmplia TherapeuticsFactor TherapeuticsPascal Biosciences
SymbolCVE:HEMLON:NSCIASX:ATXASX:FTTCVE:PAS
Price Information
Current PriceC$0.01GBX 4.25A$0.09N/AC$0.13
52 Week RangeN/AN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market CapC$3.01 million£3.34 million$4.95 million$4.17 millionC$6.84 million
BetaN/AN/AN/AN/AN/A
Average Volume376,9484,986N/A433,33456,945
Sales & Book Value
Annual RevenueN/A£317,000.00$-422.00$2.38 millionN/A
Price / SalesN/A10.53-11,717.690.00N/A
CashflowC$0.00 per shareGBX 2.27 per shareA$0.03 per shareN/AC$0.02 per share
Price / Cash10.001.883.091.007.65
Book ValueC($0.01) per shareGBX 8.40 per shareA$0.17 per shareA$0.00 per shareC$0.02 per share
Price / BookN/A0.010.550.00N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC($0.02)GBX (14.70)A($0.05)A($0.01)C($0.09)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio∞∞∞N/A∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A7.35%N/AN/AN/A
Current Ratio0.09%5.33%5.77%13.09%7.09%
Quick Ratio0.09%5.25%5.53%12.66%6.89%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
EmployeesN/A41N/AN/A4
Shares Outstanding300.90 million78.56 million53.17 million1.04 billion52.65 million
Next Earnings DateN/AN/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel